Erleada plus ADT may provide limited benefits for mCSPC patients with fewer bone metastases, affecting PFS2 and OS outcomes. Baseline bone metastasis count could guide treatment optimization for mCSPC ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Patients with bone metastases due to urothelial carcinoma had worse outcomes than those without bone ...

The American Society of Clinical Oncology first published evidence-based practice guidelines for the use of bisphosphonates in breast cancer in 2000 and updated them in 2003. To reflect the proven ...

Should Intermittent Androgen Deprivation Be Used in Routine Clinical Practice? Bone metastases are a major cause of morbidity for men with prostate cancer. Complications of bone metastases include ...

Treating high-risk, asymptomatic bone metastases with radiation may reduce painful complications and hospitalizations and possibly extend overall survival in people whose cancer has spread to multiple ...

In most cases, breast cancer with bone metastasis is incurable. Now, corresponding author Venu Raman, Ph.D., and his team say they have developed a potential novel treatment that is specific to breast ...

Rechallenge with trabectedin in patients with locally advanced or metastatic soft tissue sarcoma following drug holiday: The experience of the French Sarcoma Group (FSG). This is an ASCO Meeting ...

Please provide your email address to receive an email when new articles are posted on . Palliative radiation therapy for high-risk asymptomatic bone metastases significantly prolonged OS while ...

Case study demonstrated resolution of lytic lesions, significant reduction in pain and prevention of fracture. ZetaMet™ is a first-of-its kind molecular pathway designed to suspend cancer, inhibit ...

Source: Getty Images Radium-223, enzalutamide, and a bone-protecting agent may be a new treatment option for mCRPC patients with bone metastases, according to Silke Gillessen, MD. Radium-223 provided ...

The FEATURE study provides the first prospective validation of FDG-PET/CT and PERCIST response criteria in patients presenting with bone-only or bone-dominant metastatic breast cancer, opening the ...

Primary types of bone cancer include osteosarcoma, Ewing sarcoma, and chordoma. Secondary bone cancer develops as a result of cancer that has spread from another area of the body. Doctors broadly ...